An ounce of prevention is worth a pound of cure. Especially in the medical world, it’s far more effective and, often, more convenient to avoid an ailment entirely rather than to treat it. Occupational Health Services (OHS) at Frederick National Laboratory (FNL) has long championed this ideology, but the rise of the COVID-19 pandemic in March 2020 posed new challenges for prevention, especially for employees traveling.

Magic shows are a staple of children’s party entertainment. The sudden appearance of a cute bunny pulled from a hat or a flick of a card appearing at the top of the deck is enough to make any crowd go wild. However, for Andy Byrd, Ph.D., the thrill came from visiting his grandfather’s chemistry laboratory.

Joost “Joe” Oppenheim, M.D., senior investigator and head of the Cellular Immunology Section in the Cancer Innovation Laboratory, passed away in May. He was one of the longest-tenured scientists at NCI at Frederick. Among his many accomplishments, he has been called “the Father of Cytokines” for his pioneering role in establishing the field of cytokine research in immunology.

With Memorial Day and the 78th anniversary of D-Day on the horizon, please take a moment to locate the small memorial dedicated to nine local individuals who gave the ultimate sacrifice as part of the Allied invasion of Normandy in June 1944.

In 1972, soon after then-President Richard Nixon’s newly established Frederick Cancer Research Center (FCRC) hired its first employees, 24-year-old Kunio Nagashima put on a suit and tie and boarded a Boeing 747 at Tokyo’s Haneda International Airport. An electron microscopist from Kyoto University, Nagashima had a one-way ticket in his hand, bound for the United States and ready to take a new job—sight unseen.